Jack of All Trades
Jack of All Trades
Alcon and Nebius represent contrasting profiles: Alcon offers steady medical device quality with demographic tailwinds, while Nebius is a hypergrowth AI infrastructure bet riding the compute buildout wave.
Jack of All Trades
Nov 11 marked a quiet but telling end to earnings season—less about headline beats, more about execution, capital discipline, and strategic positioning in defensible niches. Healthcare durability and AI infrastructure optionality remained the dominant themes as Q3 reporting wrappe
Jack of All Trades
Barrick, Tyson Foods, Monday.com, Instacart, and EVgo span the spectrum from defensive real assets and consumer staples to high-growth software and EV infrastructure.
Jack of All Trades
November 7 highlighted durability over momentum: Constellation’s clean-energy moat and KKR’s fee-based model anchor stability, Wendy’s delivers steady consumer execution, while Viasat remains a higher-risk restructuring story.
Jack of All Trades
This edition of Jack of All Trades covers late Q3 reporters Constellation Energy, KKR, Wendy’s, and Viasat, assessing earnings quality, cash-flow durability, and execution as earnings season winds down.
Jack of All Trades
Costco, Adobe, Gilead, and T-Mobile earned top SKORE ratings on Nov 6—highlighting pricing power, AI monetization, oncology growth, and wireless resilience
Jack of All Trades
Costco’s resilient traffic, Adobe’s AI monetization, Gilead’s oncology surge, and T-Mobile’s wireless dominance highlighted strong and diverse earnings on November 6, 2025
Jack of All Trades
Disney turned streaming profitable, Booking and Regeneron surged on travel and drug demand, and Salesforce showed AI momentum—highlighting resilience and growth on Nov 5, 2025.
Jack of All Trades
Disney, Booking, Regeneron, and Salesforce led earnings on Nov 5, 2025—fueled by streaming profitability, travel demand, blockbuster drug sales, and AI-driven cloud growth.
Jack of All Trades
Showcases tech resilience (MSFT’s AI dominance, GOOGL’s cloud reacceleration), pharma durability (MRK’s Keytruda engine), and premium financials (AXP, DFS) benefiting from strong U.S. consumer spending.